Publikationen, an denen er mitarbeitet Óscar María Beloqui Ruiz (20)

2017

  1. Increased phagocytic NADPH oxidase activity associates with coronary artery calcification in asymptomatic men

    Free Radical Research, Vol. 51, Núm. 4, pp. 389-396

2016

  1. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: Potential role of altered collagen metabolism

    Journal of Hypertension, Vol. 34, Núm. 1, pp. 130-138

2014

  1. Association of Phagocytic NADPH Oxidase Activity With Hypertensive Heart Disease: A Role for Cardiotrophin-1?

    Hypertension, Vol. 63, Núm. 3, pp. 468-474

2011

  1. The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes

    Frontiers in Bioscience - Elite, Vol. 3 E, Núm. 4, pp. 1467-1474

2010

  1. Corrigendum to "Preliminary characterisation of the promoter of the human p22phox gene: Identification of a new polymorphism associated with hypertension" [FEBS Lett. 542 (2003) 27-31]

    FEBS Letters

  2. The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: Potential implication in hypertension (Clinical Science (2009) 116, (233-240))

    Clinical Science

2009

  1. Insulin resistance determines phagocytic nicotinamide adenine dinucleotide phosphate oxidase overactivation in metabolic syndrome patients

    Journal of Hypertension, Vol. 27, Núm. 7, pp. 1420-1430

  2. The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: Potential implication in hypertension

    Clinical Science, Vol. 116, Núm. 3, pp. 233-240

2008

  1. NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases

    Clinical Science, Vol. 114, Núm. 3-4, pp. 173-182

2007

  1. A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension

    Journal of Hypertension, Vol. 25, Núm. 8, pp. 1620-1626

  2. Oxidative stress, endothelial dysfunction and cerebrovascular disease

    Cerebrovascular Diseases

  3. Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: Implications for human atherosclerosis

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 27, Núm. 3, pp. 587-593

2006

  1. Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome

    Diabetes, Vol. 55, Núm. 1, pp. 209-215

  2. The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension

    Journal of Hypertension, Vol. 24, Núm. 7, pp. 1299-1306

2005

  1. Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production in patients with early chronic kidney disease

    Kidney International

  2. NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 25, Núm. 7, pp. 1452-1457

2004

  1. Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension

    Journal of Hypertension, Vol. 22, Núm. 11, pp. 2169-2175

  2. Estrés oxidativo en la hipertensión: De los SNPs al fenotipo clínico

    Nefrologia, Vol. 24, Núm. SUPPL.4, pp. 25-28

  3. Functional effect of the p22phox -930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension

    Hypertension, Vol. 44, Núm. 2, pp. 163-169

2003

  1. Preliminary characterisation of the promoter of the human p22phox gene: Identification of a new polymorphism associated with hypertension

    FEBS Letters, Vol. 542, Núm. 1-3, pp. 27-31